Carfilzomib
規格
868540-17-4CAS番号
692-054-2EC番号
(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamideIUPAC名
C40H57N5O7化学式
719.9 g/mol分子量
Carfilzomib; 868540-17-4; Kyprolis; PR-171; DTXSID4048690; NSC-758252; 72X6E3J5AR; DTXCID0028616; CHEBI:65347; N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide; (2S)-N-((1S)-1-Benzyl-2-(((1S)-3-methyl-1-(((2R)-2-methyloxiran-2-yl)carbonyl)butyl)amino)-2-oxoethyl)-4-methyl-2-(((2S)-2-((morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)amino)pentanamide; L-Phenylalaninamide, (alphaS)-alpha-((4-morpholinylacetyl)amino)benzenebutanoyl-L-leucyl-N-((1S)-3-methyl-1-(((2R)-2-methyloxiranyl)carbonyl)butyl)-; carfilzomibum; PR171; (2S)-N-[(1S)-1-Benzyl-2-[[(1S)-3-methyl-1-[[(2R)-2-methyloxiran-2-yl]carbonyl]butyl]amino]-2-oxoethyl]-4-methyl-2-[[(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide; N-((2S)-2-((morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)-L-leucyl-N-((2S)-4-methyl-1-((2R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)-L-phenylalaninamide; RefChem:57059; L01XX45; Carfilzomib (PR-171); Carfilzomib (PR171); MFCD11040997; (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide; C40H57N5O7; CHEMBL451887; (2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide; NCGC00249613-01; UNII-72X6E3J5AR; Carfilzomib [USAN]; CAS-868540-17-4; (alphaS)-alpha-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide; Carfilzomib [USAN:INN]; Kyprolis (TN); Carfilzomib; PR171; Carfilzomib (Standard); CARFILZOMIB [MI]; CARFILZOMIB [INN]; CARFILZOMIB [JAN]; CARFILZOMIB [VANDF]; Carfilzomib (PR-171)?; SCHEMBL85165; CARFILZOMIB [WHO-DD]; MLS006011102; Carfilzomib (JAN/USAN/INN); GTPL7420; orb1307429; CARFILZOMIB [ORANGE BOOK]; BLMPQMFVWMYDKT-NZTKNTHTSA-N; GLXC-90068; EX-A2037; ONO-7057; Tox21_113079; BDBM50277889; EBC-17178; HY-10455R; NSC756640; NSC758252; s2853; AKOS025401910; Tox21_113079_1; CCG-270405; CS-0984; CS-W004540; DB08889; FC46443; NSC 758252; NSC-756640; NCGC00249613-02; NCGC00249613-03; NCGC00249613-08; NCGC00249613-11; NCGC00249613-13; (2S)-N-[(1S)-1-benzyl-2-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]amino]-2-oxo-ethyl]-4-methyl-2-[[(2S)-2-[(2-morpholinoacetyl)amino]-4-phenyl-butanoyl]amino]pentanamide; (S)-4-Methyl-N-((S)-1-((S)-4-Methyl-1-((R)-2- Methyloxiran-2-yl)-1 -oxopentan-2-ylaMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide; AC-27051; AS-17059; BP-43632; HY-10455; SMR004660024; SY068813; NS00072616; SW218090-2; D08880; AB01565867_02; F951459; SR-01000941582; SR-01000941582-1; BRD-K15179879-001-03-2; Q15366934; (|AS)-|A-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide; (aS)-a-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalani namide; (S)-4-Methyl-N-[(S)-1-[[(S)-4-methyl-1-[(R)-2-methyloxiran-2-yl]-1-oxo-2-pentyl]amino]-1-oxo-3-phenyl-2-propyl]-2-[(S)-2-(2-morpholinoacetamido)-4-phenylbutanamido]pentanamide; L-PHENYLALANINAMIDE, (.ALPHA.S)-.ALPHA.-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-; N-{(2S)-2-[2-(Morpholin-4-yl)acetamido]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide別名
Carfilzomibを含む製品
키프롤리스주30밀리그램(카르필조밉)키프롤리스주60밀리그램(카르필조밉)KYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 10 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 10 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 10 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 60 mg, poudre pour solution pour perfusion
1/4ページ
Carfilzomibを販売する企業
DR
Dr. Reddy's LaboratoriesIndiaFK
Fresenius Kabi Oncology LimitedIndia
ML
MSN LaboratoriesIndiaHB
Hubei Biocause Heilen Pharmaceutical Co., LtdChinaCC
Chongqing Carelife PharmaceuticalChinaHR
Hangzhou Royall Import & Export Co.,LtdChinaCL
Chainpharm LimitedChinaCS
Chongqing Sintaho Pharmaceutical Co., Ltd.ChinaAP
Abydos PharmaChinaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChina1/3ページ